Article metrics

Download PDFPDF

558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to May 2024

AbstractFullPdf
Nov 2022945061
Dec 2022242016
Jan 2023206014
Feb 2023126020
Mar 2023168028
Apr 2023154041
May 2023192024
Jun 2023226018
Jul 2023176023
Aug 2023224031
Sep 2023132015
Oct 2023202030
Nov 2023372047
Dec 2023196022
Jan 202490018
Feb 2024176025
Mar 2024358042
Apr 2024396041
May 2024270041
Total48510557